Akèy › Kasinòm epitelyal ovè › Indiana › Indianapolis
Etid klinik pou Kasinòm epitelyal ovè nan Indianapolis, IN
3 etid pou Kasinòm epitelyal ovè ap chèche patisipan nan sit nan ak bò kote Indianapolis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Ap rekriteFaz 2
- Indiana University Melvin and Bren Simon Cancer Center /ID# 275492, Indianapolis
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
Ap rekriteFaz 3
- Research Site, Indianapolis
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
Ap rekriteFaz 3
- Indiana University, Indianapolis
Etid Kasinòm epitelyal ovè nan lòt vil
- Boston, MA8 etid
- Durham, NC8 etid
- New York City, NY7 etid
- San Diego, CA7 etid
- Chicago, IL7 etid
- Baltimore, MD6 etid
- Cleveland, OH6 etid
- Philadelphia, PA6 etid
- Houston, TX6 etid
- Portland, OR5 etid
- Minneapolis, MN5 etid
- Salt Lake City, UT5 etid
Lòt etid nan Indianapolis
- Kansè Poumon ki pa ti selil32 etid
- Kansè (tout kalite)24 etid
- Ensifizyans kadyak23 etid
- Obèsite20 etid
- Kansè nan tete20 etid
- Kansè Metastatik19 etid
- Kansè kolorektal18 etid
- Kansè ovè17 etid
- Maladi kadyovaskilè17 etid
- Kansè poumon16 etid
- Dyabèt tip 114 etid
- Kansè Endomèt14 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.